Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins

Journal of Breast Cancer

Volumn 16, Issue 1, 2013, Pages 23-31

  Mirza, Sameer ^a   Sharma, Gayatri ^a,b   Parshad, Rajinder ^a   Gupta, Sidhartha Datta ^a   Pandya, Pranav ^b   Ralhan, Ranju ^a,c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Dev Sanskriti Vishwa Vidhyalaya   (India)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Breast neoplasms; Chemoprevention; DNA methylation; Epigenomics

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CURCUMIN; CYCLIN D2; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; EPIGALLOCATECHIN GALLATE; ESTROGEN RECEPTOR ALPHA; GENISTEIN; GUGGULSTERONE; HISTONE DEACETYLASE 1; MASPIN; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; RESVERATROL; RETINOID RELATED ORPHAN RECEPTOR BETA; SLIT2 PROTEIN; WITHAFERIN A;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL CULTURE; CELL VIABILITY; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PAGET NIPPLE DISEASE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84876084653     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2013.16.1.23     Document Type: Article

References (29)

1. Jones PA. DNA methylation and cancer. Oncogene 2002;21:5358-60.
2. Ptak C, Petronis A. Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol 2008;48:257-76.
3. Siedlecki P, Zielenkiewicz P. Mammalian DNA methyltransferases. Acta Biochim Pol 2006;53:245-56.
4. Lyko F, Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 2005;97:1498-506.
5. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003;63:7563-70.
6. Fini L, Selgrad M, Fogliano V, Graziani G, Romano M, Hotchkiss E, et al. Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J Nutr 2007;137:2622-8.
7. King-Batoon A, Leszczynska JM, Klein CB. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 2008;49:36-45.
8. Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, et al. Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 2009;19:706-9.
9. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009;30:662-70.
10. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007;18:427-42.
11. Choi JS, Choi YJ, Park SH, Kang JS, Kang YH. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. J Nutr 2004;134:1013-9.
12. Sim GS, Lee BC, Cho HS, Lee JW, Kim JH, Lee DH, et al. Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast. Arch Pharm Res 2007;30:290-8.
13. Lee WJ, Shim JY, Zhu BT. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 2005;68:1018-30.
14. Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006;27:269-77.
15. Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C, et al. Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 2008;23:487-96.
16. Chen D, Wang CY, Lambert JD, Ai N, Welsh WJ, Yang CS. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol 2005;69:1523-31.
17. Moiseeva EP, Almeida GM, Jones GD, Manson MM. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 2007;6:3071-9.
18. Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, et al. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 2007;81:280-7.
19. Sharma G, Mirza S, Prasad CP, Srivastava A, Gupta SD, Ralhan R. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci 2007;80:1873-81.
20. Shukla S, Mirza S, Sharma G, Parshad R, Gupta SD, Ralhan R. Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics 2006;1:88-93.
21. Garinis GA, Patrinos GP, Spanakis NE, Menounos PG. DNA hypermethylation: when tumour suppressor genes go silent. Hum Genet 2002;111:115-27.
22. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
23. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-59.
24. Li Y, Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 2010;17:2141-51.
25. Rice JC, Allis CD. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr Opin Cell Biol 2001;13:263-73.
26. Prokhortchouk E, Hendrich B. Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs? Oncogene 2002;21:5394-9.
27. Fang JY, Lu YY. Effects of histone acetylation and DNA methylation on p21(WAF1) regulation. World J Gastroenterol 2002;8:400-5.
28. Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene 2000;19:4660-7.
29. Berger J, Bird A. Role of MBD2 in gene regulation and tumorigenesis. Biochem Soc Trans 2005;33(Pt 6):1537-40.